A Case of BRASH (Bradycardia, Renal Dysfunction, Atrioventricular Node Blockade, Shock, and Hyperkalemia) Syndrome Following Initiation of a Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor and a Loop Diuretic.
一例因啟用鈉-葡萄糖共轉運蛋白-2 (SGLT-2) 抑制劑和環利尿劑而引發的BRASH (心動過緩、腎功能不全、房室結阻滯、休克及高鉀血症) 綜合症。
Cureus 2024-07-23
Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.
心臟衰竭降低射出分數患者合併使用鈉葡萄糖共同運輸蛋白-2抑制劑和血管收縮素受體-內皮酶抑制劑治療引發嚴重低血壓:一個病例報告。
J Pharm Pract 2024-02-16
Beyond the Benefits: A Case Study on the Complications of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors (Euglycemic Diabetic Ketoacidosis (DKA) and Takotsubo Cardiomyopathy).
SGLT2抑制劑(Euglycemic Diabetic Ketoacidosis (DKA))和 Takotsubo 心肌病的併發症:一個個案研究。
Cureus 2024-03-30
Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights.
SGLT2 抑制劑導致的糖尿病酮酸中毒:現實世界的洞察。
Diabetes Metab J 2024-06-10
A Case of Euglycemic Diabetic Ketoacidosis Associated With a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
一例與鈉-葡萄糖共轉運蛋白-2 (SGLT2) 抑制劑相關的正常血糖性糖尿病酮症酸中毒病例。
Cureus 2025-01-09
Renal Abscess Associated with SGLT2 Inhibitors Administration in Heart Failure Without Other Previous Risk Factors: A Case Report.
心衰竭患者在未有其他風險因素下使用 SGLT2 抑制劑所引起的腎膿腫:個案報告。
Biomedicines 2025-02-26